Persistent idiopathic hypereosinophilia: A model of Th2 disorders;Hypereosinophilies chroniques: Un modele de maladie Th2

Revue du Praticien

Volumn 50, Issue 6, 2000, Pages 622-626

  Roufosse, Florence ^a   Schandené, Liliane ^a   Cogan, Élie ^a   Goldman, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOMODULATING AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR; INTERLEUKIN 2;

ARTICLE; CELL PROLIFERATION; CLONE; COCULTURE; CYTOKINE PRODUCTION; HUMAN; HYPEREOSINOPHILIA; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MODEL; SYNDROME DELINEATION; TH1 CELL; TH2 CELL; APOPTOSIS; DENDRITIC CELL; HYPEREOSINOPHILIC SYNDROME; IMMUNOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

APOPTOSIS; DENDRITIC CELLS; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERFERON-ALPHA; INTERLEUKIN-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0034654144     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Mosmann TR, Coffman RL.TH1 and TH2 cells : different patterns of lymphokine secretion lead to different functional properties.Annu Rev Immunol 1989 ; 7 : 145-73.
2. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996 ; 80 : 225-33.
3. Sanderson CJ. Interleukin 5, eosinophils, and disease. Blood 1992 ; 79 : 3101-9.
4. Schandené L, Ferster A, Mascart-Lemone F et al. T helper type 2-like cells and therapeutic effects of interferon gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol 1993 ; 23 : 56-60.
5. Wardlaw AJ. Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J 1994 ; 70 : 536-52.
6. Walsh GM. Human eosinophils : their accumulation, activation and fate. Br J Haematol 1997 ; 97 : 701-9.
7. Her E, Frazer J, Austen KF, Owen WF Jr. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991 ; 88 : 1982-7.
8. Punnonen J, Yssel H, de Vries JE.The relative contribution of IL4 and IL13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells. J Allergy Clin Immunol 1997 ; 100 : 792-801.
9. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome : analysis of fourteen cases with review of the literature. Medicine Baltimore 1975 ; 54 : 1-27.
10. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994 ; 83 : 2759-79.
11. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference.The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic and therapeutic considerations. Ann Intern Med 1982 ; 97 : 78-92.
12. Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M : Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994 ; 330 : 535-8.
13. Simon HU, Yousefi S, Dommann-Scherrer CC et al. Expansion of cytokine-producing CD4-CD8-T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996; 183: 1071-82.
14. Bank I, Reshef A, Beniaminov M, Rosenthal E, Rechavi G, Monselise Y. Role of gamma/delta T cells in a patient with CD4+CD3-lymphocytosis, hypereosinophilia, and high levels of IgE. J Allergy Clin Immunol 1998 ; 102 : 621-30.
15. Simon HU, Plotz SG, Dummer R, Blaser K. Abnormal clones ofT cells producing interleukin-5 in idio pathic eosinophilia. N Engl J Med 1999 ; 341 : 1112-20.
16. Brugnoni D, Airo P, Rossi G et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin 5. Blood 1996 ; 87 : 1416-22.
17. O'Shea JJ, Jaffe ES, Lane HC, MacDermott RP, Fauci AS. Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologie features. Am J Med 1987; 82 :539-45.
18. Kitano K, Ichikawa N, Mahbub B et al. Eosinophilia associated with proliferation of CD(3+)4-(8-) alpha beta+ T cells with chromosome 16 anomalies. Br J Hæmatol 1996 ; 92 : 315-17.
19. Willard-Gallo KE, Van de Keere F, Kettmann R.A specific defect in CD3 gammachain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci USA 1990 ; 87 : 6713-7.
20. de Waal Malefyt R, Yssel H, Spits H et al. Human T cell leukemia virus type 1 prevents cell surface expression of theT cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon and -zeta genes. J Immunol 1990; 145 : 2297-2303.
21. Furukawa M. Yasukawa M. Yakushijin Y, Fujita S: Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells. J Immunol 1994 ; 152 : 5768-75.
22. Pancake BA, Zucker-Franklin D, Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lympnotropic virus-associated disease. A study of 50 patients. J Clin Invest 1995 ; 95 : 547-54.
23. Bogen SA, Pelley D, Charif M et al. Immunophenotypic identification of Sezary cells in peripheral blood.Am J Clin Pathol 1996 ; 106 : 739-48.
24. Wood GS, Hong SR, Sasaki DT et al. Leu8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sezary syndrome relative to normal blood values. J Am Acad Dermatol 1990 ; 22 : 602-7.
25. Vowels BR, Cassin M, Vonderheid EC, Rook AH. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 1992 ; 99 : 90-4.
26. Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992 ; 13 : 74-6.
27. Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Opin Immunol 1993 ; 5 : 361-7.
28. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996 ; 14 : 233-58.
29. Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL4. Immunity 1995 ; 2 : 523-32.
30. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995 ; 80 : 707-18.
31. Roufosse F, Schandené L, Sibille C, et al. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood 94 1999 ; 994-1002.
32. Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA. CD28 costimulation promotes the production of Th2 cytokines. J Immunol 1997 ; 158 :658-665.
33. Brinkmann V, Kinzel B, Kristofic C.TCR-independent activation of human CD4+ 45RO-T cells by anti-CD28 plus IL2: induction of clonal expansion and priming for a Th2 phenotype. J Immunol 1996 ; 156 : 4100-6.
34. McCusker ME, Garifallou M, Bogen SA. Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation. J Immunol 1997 ; 158 : 4984-91.
35. Butterfield JH, Gleich GJ:Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med 1994 ; 121 : 648-53.
36. Aldebert D, Lamkhioued B, Desaint C et al. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. Blood 1996 ; 87 : 2354-60.
37. Morita M, Lamkhioued B, Soussi Gounni A et al. Induction by interferons of human eosinophil apoptosis and regulation by interleukin 3, granulocyte/macrophage-colony stimulating factor and interleukin 5. Eur Cytokine Netw 1996 ; 7: 725-32.
38. Schandené L, Del Prete GF, Cogan E et al. Recombinant interferon-alpha selectively inhibits the production of interleukin 5 by human CD4+ T cells. J Clin Invest 1996 ; 97 : 309-15.
39. Sayegh M: Finally, CTLA4lg graduates to the clinic. J Clin Invest 1999 ; 103 : 1223-5.
40. Padrid PA, Mathur M, Li X et al. CTLA4lg inhibits airway eosinophilia and hyper-responsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Respir Cell Mol Biol 1998 ; 18 : 453-62.
41. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP: Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 Inteernational Study Group. Lancet 1997 ; 350 : 1193-8.